Symposium organized by the
InternationaI Alliance for Biological Standardization





Scientific Committee

Co-chairperson:

Paul-Henri Lambert
University of Geneva
William Egan
PharmaNet
Ian Gust
University of Melbourne
Rebecca Sheets
NIH / NIAID



Meeting management:

Dodet Bioscience
Lyon
Objectives
  • This meeting will bring together experts from the biological industry, academia and regulatory agencies to review the possibility of introducing new selected biomarkers in the assessment of vaccine safety at pre-clinical and early clinical stages (inflammation and early immunological events).

Goals
  • The goal of the meeting is to facilitate the integration of recent scientific advances into vaccine regulatory processes.

Who should attend?
  • This event will be of interest to experts working in the field of human vaccines, whether from the public or private sector or from regulatory agencies.


Meeting Venue

Hyatt Inner Harbor Hotel
300 Light Street Baltimore, MD, USA
www.marriott.com/hotels/travel/bwiwf-baltimore-marriott-waterfront

Workshop organized by IABS
IABS



Sponsors :

Abbot

Novartis                CSL


Sanofi Pasteur